-----Original Message----- From: Rees Beth Sent: Thursday, November 08, 2001 11:44 AM To: cyto-inbox Subject: RE: CD38 and CLL/SLL Hi Christopher, We are currently running CD79b/CD38/CD20, although we don't always report it, but if you're getting requests maybe this is a good time to begin. The CD79b is because we are also assessing its usefulness, but so far we're not impressed. Theoretically its supposed to be absent in CLL, but we haven't found that to be consistent. yours, beth Beth Rees Flow Cytometry Lab Pathology Dept Royal Hobart Hospital Hobart, Tasmania Australia ph. 03 6222 8913 -----Original Message----- From: Bee Christopher S Maj 859 MDTS/MTLLI [mailto:Christopher.Bee@WHMC.AF.MIL] Sent: Wednesday, November 07, 2001 3:38 AM To: cyto-inbox Subject: CD38 and CLL/SLL Given the recent publication of another article documenting the association of CD38 expression on CLL/SLL and a worse prognosis, our clinicians are beginning to ask us to give CD38 results on a more frequent basis. Are other labs performing this routinely in the evaluation of small B-cell lymphoprolifertaive disorders and, if so, what are you running the CD38 in combination with? Thanks in advance for any input. Sincerely, Christopher S. Bee, M.D. Medical Director, Cellular Immunology/Flow Cytometry Wilford Hall Medical Center, Lackland AFB, TX (210) 292-5455 DSN 554-5455 (210) 292-7484 (Fax)
This archive was generated by hypermail 2b29 : Sun Jan 05 2003 - 19:01:38 EST